CYP11B1 Antibodies

Santa Cruz Biotechnology delivers a wide array of CYP11B1 monoclonal antibodies for research focused on understanding this critical enzyme. CYP11B1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP11B1, also known as 11β-hydroxylase, is essential for the biosynthesis of glucocorticoids and mineralocorticoids in the adrenal cortex. The enzyme plays a significant role in regulating blood pressure, electrolyte balance, and stress response. Dysregulation of CYP11B1 can lead to various disorders, including hypertension and adrenal hyperplasia, making it a vital target for research in endocrinology and metabolic diseases. Understanding CYP11B1 function and regulation is crucial for developing therapeutic strategies for related disorders. Research utilizing CYP11B1 monoclonal antibodies continues to reveal new insights into hormone synthesis and regulation pathways. Investigating CYP11B1 expression patterns helps identify potential therapeutic targets for treating endocrine disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of CYP11B1's role in human health and disease.